Market Outlook

By 2035, the U.S. Orthopedic Ambulatory Surgery Center Devices Market is projected to reach approximately USD 14.00 billion, expanding at an aggressive CAGR of 9.44% during 2026–2035. The market was valued at an estimated USD 5.68 billion in 2025, with historical analysis covering 2021–2024. All market values are expressed in USD billions.

The market includes orthopedic implants, surgical instruments, arthroscopy systems, powered tools, visualization equipment, navigation platforms, robotic-assisted surgery systems, spine technologies, orthobiologics, disposable accessories, sterilization-related products, and procedure-specific consumables purchased for use in U.S. ambulatory surgery centers. The estimate excludes surgeon professional fees, ASC facility reimbursement, pharmaceuticals, postoperative rehabilitation services, and orthopedic procedures performed in hospital inpatient departments.

Orthopedic surgery is becoming one of the most strategically important service lines within the U.S. ASC industry. The country had approximately 6,436 Medicare-certified ASCs in 2024, up 2.2% from the prior year. Orthopedic specialization expanded considerably faster than the broader ASC base. The number of Medicare-billing single-specialty orthopedic ASCs increased by 18.9% during 2024, while multispecialty centers combining pain management and orthopedics increased by 20.9%. These developments indicate that orthopedic procedures are becoming a central component of ASC formation, expansion, and capital investment.

Demand is being accelerated by the migration of total knee, total hip, shoulder, spine, sports medicine, trauma, and extremity procedures from hospital settings to freestanding or hospital-affiliated surgery centers. Medicare ASC volumes for total knee arthroplasty and total hip arthroplasty increased by 27.6% and 28.7%, respectively, during 2024. Medicare reimbursement for total shoulder arthroplasty in ASCs also began in 2024, creating an additional device-intensive outpatient procedure category.

The historical market expanded from approximately USD 3.64 billion in 2021 to USD 5.15 billion in 2024. Estimated values reached USD 4.11 billion in 2022 and USD 4.61 billion in 2023. Growth during this period was supported by the recovery of elective orthopedic surgery, broader payer acceptance of same-day joint replacement, expansion of physician-owned orthopedic ASCs, increasing use of robotic-assisted systems, and greater availability of implants and instruments designed specifically for outpatient workflows.

By 2030, the market is projected to exceed USD 8.91 billion. Growth will increasingly depend on whether manufacturers can support high clinical quality while meeting ASC-specific economic requirements. Devices that reduce instrument trays, sterilization labor, operating-room time, inventory exposure, physical footprint, and postoperative complications are expected to gain preference over systems originally designed primarily for large hospital operating rooms.

The central market opportunity is therefore broader than transferring existing orthopedic devices into an outpatient location. Manufacturers must redesign their commercial, service, inventory, training, and technology models around the distinctive economics of an ASC. Systems that provide procedural consistency, lower total episode cost, faster room turnover, predictable implant availability, and scalable surgeon adoption will capture a disproportionate share of market growth through 2035.

 

Introduction

According to the U.S. Orthopedic Ambulatory Surgery Center Devices Market Report, the industry is positioned at the intersection of orthopedic procedural growth, site-of-care migration, reimbursement reform, physician entrepreneurship, and medical technology innovation. ASCs primarily treat patients who can be discharged without an overnight hospital stay. Their operating model emphasizes predictable case scheduling, standardized care pathways, focused clinical teams, lower overhead, and more rapid patient movement than conventional hospital departments.

Orthopedics is particularly suitable for ASC expansion because many procedures are elective, protocol-driven, implant-intensive, and concentrated among a relatively small number of trained surgeons. Appropriate patient selection, multimodal pain management, minimally invasive techniques, blood-loss control, rapid mobilization, and structured home-recovery pathways have made same-day surgery feasible for a growing range of musculoskeletal conditions.

The addressable device ecosystem is diverse. High-value revenue is generated by knee, hip, shoulder, spine, trauma, foot and ankle, and upper-extremity implants. Recurring revenue comes from anchors, sutures, fixation devices, shavers, burrs, blades, irrigation tubing, cannulas, sterile drapes, electrosurgical accessories, and procedure packs. Capital expenditure includes arthroscopy towers, surgical tables, C-arms, robotic platforms, navigation systems, sterilization equipment, powered instruments, and digital planning infrastructure.

ASC device purchasing differs materially from hospital procurement. Many centers do not have the capital budgets, storage capacity, sterile-processing infrastructure, biomedical engineering support, or vendor-management resources of a large hospital. They therefore favor compact equipment, modular platforms, reusable instruments with fewer trays, predictable maintenance, rapid technical support, and financing arrangements that preserve cash. Implant pricing must also fit within the facility payment received for the procedure.

Facility ownership further shapes purchasing behavior. Physician-owned centers may prioritize systems that improve surgeon control, throughput, and distributions to owners. Hospital-affiliated ASCs often standardize products with an integrated delivery network but may negotiate separate outpatient pricing. Corporate-backed networks can use aggregated procedure volume to obtain national contracts, while independent orthopedic centers may maintain deeper relationships with a smaller number of local representatives.

The market-sizing methodology applies a bottom-up framework incorporating orthopedic procedure volumes in ASCs, implant utilization, average selling prices, disposable consumption, capital-equipment placements, replacement cycles, software and service revenue, facility openings, and procedure migration from hospital outpatient departments. The forecast also considers Medicare policy, commercial payer steering, demographic demand, state-level ASC penetration, surgeon ownership trends, and the adoption curve for robotics and navigation.

For report buyers, the most important questions concern where orthopedic procedure migration will be fastest, which device categories can retain premium pricing, how ASC procurement differs from hospital purchasing, and which states offer the strongest combination of procedure demand and favorable operating conditions. These factors will determine commercial territory design, distributor strategy, account segmentation, clinical education investment, and portfolio development.

 

Key Market Drivers: What’s Fueling the U.S. Orthopedic Ambulatory Surgery Center Devices Market Boom?

The first major driver is the scale of musculoskeletal disease in the United States. Approximately 53.2 million American adults have diagnosed arthritis, representing more than one-fifth of the adult population. Arthritis prevalence rises sharply with age and exceeds half of adults aged 75 years and older. Osteoarthritis, degenerative joint disease, spinal disorders, sports injuries, fractures, tendon damage, and mobility-related conditions create sustained demand for orthopedic intervention.

Population aging strengthens this underlying demand. Older adults account for a significant share of hip, knee, shoulder, spine, and fracture-related procedures. At the same time, active middle-aged patients increasingly seek earlier surgical intervention to restore mobility, return to employment, and maintain recreational activity. This expands the ASC candidate pool beyond elderly Medicare beneficiaries to commercially insured patients seeking convenient and lower-cost treatment.

The second driver is the rapid movement of orthopedic procedures away from hospital inpatient care. Medicare coverage of total knee arthroplasty in ASCs began in 2020, followed by total hip arthroplasty in 2021 and total shoulder arthroplasty in 2024. Commercial payers had already supported selected outpatient joint replacement programs, and Medicare eligibility has strengthened the business case for ASC investment in implants, instrumentation, operating tables, robotics, and recovery infrastructure.

Procedure migration is no longer limited to straightforward arthroscopy. Carefully selected patients now undergo partial and total knee replacement, total hip replacement, shoulder arthroplasty, lumbar decompression, spinal fusion, sacroiliac joint fusion, foot and ankle reconstruction, fracture fixation, and upper-extremity surgery in outpatient facilities. Expansion of the ASC-covered procedure list and the gradual removal of musculoskeletal procedures from inpatient-only restrictions could widen the addressable device market further.

The third driver is the procedure economics of ASCs. Medicare payment rates for services performed in ASCs are generally lower than equivalent hospital outpatient rates, creating savings for both beneficiaries and the Medicare program. Lower facility reimbursement places pressure on centers to manage implant costs, but it also encourages payers to direct appropriate patients toward ASCs. Commercial insurers increasingly use benefit design, prior authorization, bundled payments, and preferred-provider programs to support lower-cost sites of care.

For device manufacturers, the economic opportunity arises from volume growth rather than unrestricted pricing. A center performing a high number of standardized orthopedic cases can generate substantial recurring demand for implants and consumables. Vendors that help improve room utilization, reduce case variability, lower sterile-processing expense, and avoid unused inventory can preserve margins even when unit prices face pressure.

The fourth driver is physician ownership and clinical control. Most U.S. ASCs have at least some physician ownership, and more than 95% of Medicare-certified centers operate on a for-profit basis. Orthopedic surgeons may prefer ASCs because they can influence staffing, implant selection, block scheduling, instrumentation, and operating-room design. This autonomy can shorten nonoperative time and allow more cases to be performed during a surgical day.

Physician ownership also changes the device sales process. Surgeons remain clinically influential, but they are simultaneously exposed to the facility’s financial performance. Purchasing decisions therefore involve a direct evaluation of clinical preference against implant expense, capital amortization, maintenance cost, tray-processing requirements, and reimbursement. Suppliers must engage both the surgeon and the center’s administrator, procurement lead, nursing team, and financial partners.

The fifth driver is consolidation among ASC operators, health systems, payers, and orthopedic groups. Major corporate owners have continued to increase their stakes in surgery centers, while orthopedic practices are forming larger regional platforms. Consolidated organizations can standardize implants, negotiate system-wide pricing, centralize data analytics, and replicate successful joint-replacement pathways across multiple facilities. This favors manufacturers capable of national contracting, dependable distribution, and multi-site implementation.

The sixth driver is the emergence of outpatient-appropriate robotic and navigation technology. Earlier orthopedic robotic platforms were designed around hospital capital budgets and large operating rooms. Newer systems use smaller footprints, image-free workflows, handheld instruments, modular configurations, and financing structures that are more compatible with ASCs. Robotics is increasingly viewed as a tool for standardization, surgeon recruitment, patient differentiation, and procedural growth rather than only as a premium capital purchase.

The seventh driver is expansion of value-based orthopedic care. Bundled payments and episode-based contracting encourage providers to control the total cost of surgery, complications, readmissions, rehabilitation, and follow-up. Devices that support accurate implant positioning, tissue preservation, predictable pain control, rapid ambulation, and remote recovery monitoring can contribute to a more reliable episode of care. Clinical quality remains essential because an avoidable transfer or readmission can materially affect both patient outcomes and ASC economics.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. orthopedic ASC device market is increasingly directed toward operational suitability rather than technological complexity alone. Manufacturers are being evaluated on whether their products can deliver reproducible outcomes in a facility with limited storage, limited sterile-processing capacity, lean staffing, and a tightly controlled procedure budget.

Compact robotic-assisted surgery is one of the most visible innovation areas. Handheld robotic tools and small-footprint platforms can reduce the space, installation, and workflow requirements associated with traditional robotic arms. Image-free systems can also eliminate preoperative computed tomography in selected procedures, reducing planning complexity and avoiding an additional diagnostic step. For ASCs, the most commercially viable robotic systems will combine accuracy with rapid setup and flexible acquisition models.

Navigation and digital planning technologies are also moving into outpatient orthopedics. These include computer-assisted implant positioning, patient-specific planning, intraoperative balancing, augmented visualization, 3D anatomical modeling, and data-driven surgical guidance. The strategic value of these systems lies in reducing variability between cases and helping a center support multiple surgeons without maintaining highly customized manual workflows for each physician.

Implant and instrumentation design is becoming more ASC-oriented. Manufacturers are reducing the number of trays required for joint replacement and spine procedures, consolidating instrument sets, introducing sterile-packed implants, and increasing compatibility across implant families. Fewer trays can reduce sterilization cycles, handling time, storage needs, and the risk of missing instruments. These operational benefits can be economically significant for a high-volume center.

Sports medicine innovation is focused on tissue-preserving repair, knotless fixation, all-suture anchors, biologically supportive scaffolds, and single-use arthroscopic technologies. Shoulder, knee, hip, elbow, and ankle arthroscopy remain core ASC procedures because they are well established in outpatient care. Manufacturers are differentiating through fixation strength, ease of deployment, smaller drill requirements, visualization quality, and procedure-specific disposable kits.

Spine technology is evolving toward less invasive approaches that can support outpatient recovery. Expandable cages, minimally invasive fixation, navigation, robotic screw placement, endoscopic decompression, lateral access systems, and sacroiliac joint implants are broadening ASC procedure capabilities. Adoption nevertheless depends on patient selection, anesthesia protocols, surgeon experience, emergency-transfer arrangements, and alignment between device cost and facility reimbursement.

Orthobiologics and regenerative products are another innovation area, although evidence and reimbursement vary by product. Bone graft substitutes, cellular allografts, demineralized bone matrices, synthetic matrices, and soft-tissue augmentation materials are used across spine, trauma, extremity, and sports medicine procedures. ASC buyers seek products that provide clinical utility without introducing excessive cost, storage complexity, or uncertain reimbursement.

Digital recovery platforms are extending innovation beyond the operating room. Mobile applications, wearable sensors, automated patient messaging, remote range-of-motion assessment, and patient-reported outcome collection can support preoperative education and postoperative monitoring. These tools may help identify recovery problems before they lead to an emergency visit, while also generating outcome evidence for payers and prospective patients.

 

Segmentation Insights

The U.S. Orthopedic Ambulatory Surgery Center Devices Market is segmented on the basis of product category, procedure type, end user, technology type, and region.

 

By Product Category

• Joint reconstruction implants and instruments represent the largest product category by value. The segment includes total and partial knee systems, hip stems, acetabular cups, bearing surfaces, shoulder implants, revision components, trial instruments, reamers, broaches, and procedure-specific instrumentation. Growth is supported by the rapid increase in same-day arthroplasty and the inclusion of shoulder replacement in Medicare ASC reimbursement. Vendors are competing through implant survivorship, streamlined trays, robotic compatibility, and outpatient pricing.
• Sports medicine and arthroscopy devices provide a large base of recurring procedure revenue. This segment includes suture anchors, interference screws, buttons, fixation systems, graft-preparation products, arthroscopes, cameras, light sources, fluid-management systems, shavers, burrs, ablation probes, cannulas, and sutures. Demand is supported by rotator cuff repair, anterior cruciate ligament reconstruction, meniscal repair, labral repair, cartilage procedures, and tendon reconstruction.
• Spine surgery devices are expected to produce above-average growth as appropriate decompression, fusion, disc, and sacroiliac procedures migrate to outpatient facilities. Products include pedicle screws, rods, plates, interbody cages, expandable implants, biologics, navigation tools, endoscopic systems, and minimally invasive access devices. The commercial opportunity is concentrated in experienced centers with robust patient-selection, anesthesia, postoperative monitoring, and transfer protocols.
• Trauma, extremity, and small-joint devices include fracture plates, screws, intramedullary fixation, external fixation, hand and wrist implants, foot and ankle systems, hammertoe devices, bunion-correction systems, and upper-extremity reconstruction products. This segment benefits from the high suitability of many extremity procedures for outpatient care. Sterile-packed and procedure-specific systems are particularly attractive because they reduce inventory and reprocessing requirements.
• Orthobiologics, surgical instruments, and consumables include bone graft substitutes, demineralized matrices, soft-tissue augmentation materials, power-tool accessories, saw blades, drill bits, irrigation products, sterile drapes, procedure packs, tourniquet supplies, electrosurgical accessories, and wound-closure products. While individual selling prices are lower than implant prices, recurring utilization creates a stable revenue pool. Manufacturers can gain share through standardization and multi-category contracting.

 

By Procedure Type

• Knee replacement procedures constitute the largest procedure-based segment. Total knee arthroplasty, unicompartmental knee replacement, and selected revision procedures require implants, balancing instruments, powered tools, cement or cementless fixation products, navigation, and robotic support. Knee replacement is especially attractive for ASCs because procedures can be standardized across patient preparation, anesthesia, implant selection, physical therapy, and same-day discharge.
• Hip replacement procedures are another high-value segment with rapid outpatient adoption. Direct anterior and other muscle-sparing approaches have supported earlier mobilization and same-day discharge in selected patients. Device demand includes stems, acetabular shells, liners, femoral heads, surgical tables, imaging, navigation, impactors, broaches, and automated impaction systems. Implant cost and procedure time remain central procurement considerations.
• Shoulder reconstruction and arthroscopy procedures are positioned for significant growth. Medicare ASC coverage of total shoulder arthroplasty has improved the market opportunity for anatomic and reverse shoulder implants, glenoid components, humeral systems, patient-specific planning, navigation, and robotic assistance. Arthroscopic shoulder repair remains a large recurring market for anchors, sutures, shavers, fluid management, visualization, and biologic augmentation.
• Sports medicine and soft-tissue procedures include ligament reconstruction, meniscal repair, rotator cuff repair, instability procedures, cartilage treatment, tendon repair, and hip arthroscopy. These procedures have a long-established ASC presence and benefit from younger commercially insured patients. Market competition is driven by surgeon loyalty, clinical education, anchor and fixation design, procedural efficiency, and the breadth of disposable portfolios.
• Spine, trauma, and extremity procedures represent a diversified growth segment. Outpatient spine surgery delivers high device value per case but requires disciplined clinical pathways. Foot, ankle, hand, wrist, elbow, and fracture procedures provide broader recurring volume and are feasible in a wide range of centers. Manufacturers with focused extremity portfolios can compete effectively without matching the scale of diversified orthopedic companies.

 

By End User

• Orthopedic single-specialty ASCs are the most strategically important end users for procedure-specific implants and enabling technologies. These centers typically maintain concentrated surgeon relationships, specialized operating rooms, and standardized orthopedic protocols. Their focused case mix can justify investment in robotics, navigation, dedicated surgical tables, and implant inventory when procedure volumes are sufficient.
• Multispecialty ASCs with orthopedic programs represent a large and expanding buyer group. Orthopedics may be combined with pain management, general surgery, podiatry, or other specialties. These facilities must balance orthopedic capital investment against competing service lines, making equipment utilization and footprint especially important. Modular platforms and shared visualization, imaging, sterilization, and operating-room infrastructure have an advantage.
• Physician-owned independent ASCs frequently offer direct access to clinical decision-makers and can adopt new devices quickly when surgeons understand both the clinical and economic case. However, they may have limited negotiating leverage, financing capacity, and administrative resources. Vendors that provide responsive local service, consignment inventory, flexible payment terms, and staff training can build durable relationships.
• Hospital-affiliated and joint-venture ASCs combine outpatient efficiency with health-system referral networks, payer contracts, and procurement infrastructure. They may standardize implants with affiliated hospitals to simplify surgeon preference, contracting, and inventory management. Conversely, some joint ventures use the ASC to renegotiate orthopedic pricing separately from hospital agreements, particularly when facility reimbursement is substantially lower.
• Corporate-backed and networked ASC operators are becoming more influential in device procurement. Large operators can aggregate orthopedic procedure volume, negotiate national agreements, compare performance across facilities, and replicate standardized clinical pathways. Manufacturers seeking access to these networks must demonstrate supply reliability, national service coverage, transparent pricing, and measurable economic value at both the facility and enterprise levels.

 

By Technology Type

• Conventional manual orthopedic technologies continue to account for the largest installed base. Manual cutting guides, broaches, reamers, alignment systems, standard arthroscopy, traditional fixation, and non-navigated instrumentation remain widely used because they are familiar, reliable, and comparatively economical. Their long-term position will depend on continued improvements in tray efficiency, ergonomics, and compatibility with outpatient workflows.
• Robotic-assisted orthopedic systems are expected to record the fastest value growth. Adoption is strongest in knee replacement but is broadening into hip, shoulder, and spine surgery. ASC growth will favor systems with a limited footprint, short setup time, low imaging requirements, reusable or economical instrumentation, and financing that can be supported by case volume.
• Computer navigation and patient-specific planning provide an intermediate option between fully manual and robotic surgery. These technologies support implant alignment, joint balancing, spinal instrumentation, and anatomical planning without always requiring a large robotic capital purchase. Their appeal is strongest when they can integrate with existing implants and provide measurable procedural consistency.
• Arthroscopic and minimally invasive technologies remain central to outpatient orthopedics. High-definition and 4K visualization, fluid management, powered resection, radiofrequency ablation, small-incision instruments, endoscopic spine systems, and minimally invasive access tools can reduce tissue disruption and support faster recovery. Recurring disposable consumption gives this technology category a dependable revenue profile.
• AI-enabled, connected, and data-driven technologies are emerging across preoperative planning, intraoperative guidance, inventory management, patient engagement, and postoperative recovery. Their direct revenue contribution remains smaller than implants and capital equipment, but their influence on purchasing is increasing. Platforms that connect clinical data with workflow and outcome measurement may become important differentiators in value-based orthopedic contracting.

 

Regional Insights: Where the Market is Growing Fastest

The market is geographically divided into the South, West, Northeast, and Midwest. Regional performance depends on population growth, age distribution, orthopedic disease burden, ASC density, certificate-of-need regulation, payer behavior, physician ownership, health-system strategy, and access to orthopedic specialists. The South represented the largest regional market in 2025, while the West is expected to record the fastest growth through 2035.

South

The South accounted for an estimated USD 2.10 billion in 2025, representing approximately 37% of the national market. It is projected to reach about USD 5.23 billion by 2035. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Delaware, West Virginia, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma, and the District of Columbia.

Texas is the largest Southern state market because of its population scale, rapid metropolitan growth, extensive physician-owned ASC base, and major orthopedic networks in Dallas–Fort Worth, Houston, Austin, and San Antonio. Texas supports high volumes across joint replacement, sports medicine, spine, and extremity surgery. Competitive device purchasing is shaped by independent physician groups, hospital joint ventures, and expanding corporate ASC operators.

Florida is another critical market because of its older population and high demand for joint reconstruction, spine, shoulder, and mobility-restoring procedures. Medicare exposure is substantial, making reimbursement eligibility and same-day discharge protocols particularly important. South Florida, Tampa, Orlando, Jacksonville, and the Gulf Coast are major orthopedic growth corridors.

Georgia has one of the country’s highest ratios of ASCs to Medicare beneficiaries and has introduced exemptions affecting certain single-specialty ASC developments. Atlanta and surrounding suburban markets provide strong demand for sports medicine, arthroplasty, and spine technologies. North Carolina’s easing of ASC certificate-of-need requirements in higher-population counties is expected to support facility development in Charlotte, Raleigh-Durham, Greensboro, and other expanding markets.

South Carolina eliminated ASC certificate-of-need requirements in 2023, creating a more favorable development environment. Tennessee benefits from established healthcare companies, Nashville-based surgery-center expertise, and growing orthopedic networks. Virginia and Maryland combine affluent payer markets with sophisticated health systems. Maryland has the highest concentration of ASCs per Medicare beneficiary, influenced partly by its distinctive hospital payment model and incentives to provide appropriate care outside hospital departments.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have considerable musculoskeletal disease burdens but uneven access to specialty surgery. Major cities support advanced orthopedic ASCs, while rural areas remain dependent on hospital systems and regional referral centers. Compact equipment, mobile imaging, standardized implants, and service models that can support lower-volume centers may be especially relevant.

Delaware and the District of Columbia are smaller markets but benefit from dense regional referral networks. The South’s long-term leadership will be supported by migration, population aging, physician investment, regulatory liberalization in selected states, and continued construction of orthopedic-focused outpatient facilities.

West

The West generated an estimated USD 1.27 billion in 2025 and is projected to reach approximately USD 3.35 billion by 2035, making it the fastest-growing region. The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, Idaho, Montana, Wyoming, New Mexico, Alaska, and Hawaii.

California is the region’s largest state market. Los Angeles, Orange County, San Diego, the San Francisco Bay Area, Sacramento, and the Inland Empire support high orthopedic procedure volumes and advanced technology adoption. The state has a significant commercial insurance base, influential academic centers, large orthopedic groups, and strong medtech innovation activity. High labor and facility costs increase interest in technologies that improve room turnover and reduce staffing requirements.

Arizona combines rapid population growth, retiree migration, and a high concentration of ASCs relative to Medicare beneficiaries. Phoenix, Scottsdale, Tucson, and surrounding communities are important markets for joint replacement, spine, shoulder, and foot and ankle devices. Nevada also has high ASC penetration, with Las Vegas and Reno supporting growing outpatient orthopedic infrastructure.

Washington and Oregon are characterized by integrated health systems, evidence-driven procurement, and strong acceptance of digital care. Seattle, Portland, Spokane, and other urban areas offer opportunities for navigation, robotic surgery, remote recovery, and value-based contracting. Buyers may require robust evidence of clinical benefit and total-cost improvement before adopting premium technologies.

Colorado and Utah combine population growth with expanding orthopedic specialty capacity. Denver, Colorado Springs, Salt Lake City, and Utah County are attractive markets for sports medicine, arthroplasty, spine, and digital surgery. Both states have active populations and strong demand for mobility-restoring procedures. Utah also has relatively high ASC penetration and an established medical-device ecosystem.

Idaho, Montana, and Wyoming have smaller populations but comparatively high ASC availability in selected areas. Their markets are concentrated around regional urban centers and may favor multi-use equipment, efficient instrumentation, and dependable distributor support. New Mexico’s ASC concentration is lower than might be expected in a state without broad certificate-of-need restrictions, partly because of rural geography and specialist availability.

Alaska and Hawaii face distinctive logistical challenges, including freight expense, limited inventory flexibility, geographic separation, and constrained specialist supply. Vendors must provide reliable forecasting and distribution support. The West’s overall growth will be driven by population migration, technology adoption, ASC development, and demand for compact robotic, navigation, and connected-care platforms.

Northeast

The Northeast represented approximately USD 1.18 billion in 2025 and is forecast to reach around USD 2.79 billion by 2035. The region includes New York, New Jersey, Pennsylvania, Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire, and Vermont.

New York is the largest Northeastern market, supported by dense provider networks, major academic institutions, high procedure volumes, and affluent commercial payer segments. The New York City metropolitan area is clinically advanced but operationally expensive, favoring technologies that reduce surgical time and space requirements. Upstate markets depend more heavily on regional orthopedic groups and health-system partnerships.

New Jersey has comparatively high ASC penetration and a large base of physician-owned outpatient facilities. Its population density and proximity to New York and Philadelphia support strong demand for sports medicine, spine, joint replacement, and extremity devices. Pennsylvania combines large metropolitan markets in Philadelphia and Pittsburgh with extensive community and rural healthcare networks. The state’s ASC financial data also indicate that surgery centers can achieve attractive operating margins.

Massachusetts is highly influential because of its academic hospitals, clinical research activity, and sophisticated purchasing standards. Its total market is smaller than New York or Pennsylvania, but the state is an important early-evaluation location for orthopedic technology. Connecticut and Rhode Island have mature healthcare markets and strong potential for hospital–physician ASC joint ventures.

Maine, New Hampshire, and Vermont are smaller markets with older populations and rural access constraints. Vermont has one of the lowest ASC concentrations in the country, partly reflecting strict certificate-of-need controls. New Hampshire has a more favorable outpatient presence and can serve patients from surrounding states. Manufacturers addressing northern New England must accommodate lower volumes and wider service territories.

The Northeast will grow more slowly than the South and West because of mature infrastructure, slower population growth, and regulatory constraints in several states. It will nevertheless remain a premium market for robotic surgery, navigation, advanced shoulder systems, complex sports medicine, and evidence-supported implants.

Midwest

The Midwest accounted for an estimated USD 1.13 billion in 2025 and is expected to reach approximately USD 2.63 billion by 2035. The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the region’s largest market, with Chicago supporting major health systems, academic centers, orthopedic groups, and ASC joint ventures. Ohio has substantial orthopedic procedure capacity across Cleveland, Columbus, Cincinnati, Dayton, and other metropolitan markets. Both states offer strong demand for joint reconstruction, sports medicine, spine, and trauma devices.

Michigan has a mature orthopedic infrastructure and considerable demand related to arthritis, industrial workforce exposure, and population aging. Indiana combines established orthopedic practices with favorable access to ambulatory surgery in several markets. Wisconsin has integrated health systems and a strong regional referral structure, while Minnesota is strategically important because of its medtech industry, orthopedic expertise, and sophisticated provider organizations.

Missouri, Iowa, and Kansas offer stable procedure demand across metropolitan and regional markets. Kansas has relatively high ASC availability, creating opportunities for outpatient joint replacement and extremity procedures. Missouri’s principal markets in St. Louis and Kansas City support advanced orthopedic care, while Iowa relies on a mix of health-system-affiliated and independent facilities.

Nebraska, North Dakota, and South Dakota have smaller population bases and substantial rural areas. Orthopedic ASC demand is concentrated in cities such as Omaha, Lincoln, Fargo, Sioux Falls, and Bismarck. These states require scalable equipment, efficient inventory deployment, and regional service coverage. Remote preoperative assessment and postoperative monitoring may help extend outpatient orthopedic pathways across large geographic areas.

The Midwest is expected to provide durable rather than exceptional growth. Manufacturers can succeed through cost-effective contracting, strong field support, surgeon education, and products that fit community-based orthopedic care. The region will remain an important base for manual systems while gradually increasing adoption of smaller robotic and navigation platforms.

 

Key Market Players

The U.S. Orthopedic Ambulatory Surgery Center Devices Competitive Landscape is moderately consolidated in large-joint reconstruction and enabling technologies but remains fragmented across sports medicine, spine, extremities, biologics, visualization, and procedure-specific consumables.

Leading diversified orthopedic manufacturers benefit from broad implant portfolios, established surgeon relationships, clinical education infrastructure, and the ability to bundle devices across multiple procedures. Specialized companies can compete by addressing a focused workflow problem, developing ASC-compatible technology, or providing differentiated products in spine, foot and ankle, shoulder, sports medicine, and minimally invasive surgery.

Some of the key players in the U.S. Orthopedic Ambulatory Surgery Center Devices industry are:

Stryker
Zimmer Biomet
Johnson & Johnson MedTech–DePuy Synthes
Smith+Nephew
Arthrex
Medtronic
Globus Medical
Enovis
CONMED Corporation
Orthofix Medical
Alphatec Holdings
SI-BONE
Exactech
MicroPort Orthopedics
Paragon 28, a Zimmer Biomet company
Treace Medical Concepts
Acumed
B. Braun–Aesculap
KARL STORZ
Olympus Corporation
Brainlab
THINK Surgical
GE HealthCare
Siemens Healthineers
Medline Industries

Stryker, Zimmer Biomet, DePuy Synthes, and Smith+Nephew hold strong positions in joint reconstruction and orthopedic enabling technologies. Arthrex and CONMED are influential in sports medicine and arthroscopy. Medtronic, Globus Medical, Orthofix, Alphatec, and SI-BONE compete in spine and sacroiliac procedures. Enovis, Paragon 28, Treace, Acumed, and Exactech strengthen competition across extremities, shoulder, and reconstruction.

Capital-equipment and visualization suppliers are becoming more relevant as ASCs increase procedure complexity. KARL STORZ and Olympus support arthroscopic visualization, while GE HealthCare and Siemens Healthineers supply mobile imaging technologies used in spine, trauma, and extremity surgery. Brainlab and THINK Surgical participate in navigation and robotic-assisted workflows.

Future market share will be influenced by implant economics, ASC-specific product design, clinical evidence, surgeon training, financing flexibility, tray reduction, inventory management, technical service, and national contracting. Companies that attempt to transfer hospital pricing and infrastructure requirements directly into ASCs may lose share to more adaptable competitors.

 

Recent Developments

The regulatory environment expanded materially in 2026. CMS began a phased removal of procedures from the inpatient-only list and added hundreds of services to the ASC-covered procedure list. The first phase included a substantial number of musculoskeletal codes, including selected total hip revision and spinal procedures. Although actual migration will depend on patient selection and center capability, the policy broadens the long-term addressable market for orthopedic devices in ASCs.

Orthopedic procedure volumes in ASCs continued to grow at double-digit rates. During 2024, Medicare total knee arthroplasty volume increased by 27.6%, while total hip arthroplasty increased by 28.7%. Total shoulder arthroplasty also became reimbursable in Medicare ASCs. These changes are encouraging centers to invest in joint-replacement instrumentation, operating tables, implant inventory, navigation, and postoperative recovery capabilities.

Stryker expanded the Mako platform in 2026 through the U.S. commercial introduction of a handheld robotic power system for total knee replacement. The platform targets customers seeking robotic execution and intraoperative planning with a workflow closer to conventional powered instrumentation. Smaller and more flexible robotic formats are particularly relevant to ASCs that cannot support the footprint or utilization requirements of a traditional robotic arm.

Johnson & Johnson MedTech expanded the VELYS ecosystem across knee and spine surgery. The VELYS Robotic-Assisted Solution received an expanded U.S. indication for unicompartmental knee arthroplasty, while the VELYS Spine platform introduced active robotic assistance and standalone navigation for spinal fusion workflows. Image-free and multi-indication systems can improve the economic case for adoption across outpatient facilities.

Zimmer Biomet received U.S. clearance for the ROSA Shoulder system and initiated commercial availability during the second half of 2024. The development extends robotic-assisted technology beyond knee and hip procedures into shoulder replacement, an area with growing ASC relevance following Medicare reimbursement expansion.

Smith+Nephew introduced CORIOGRAPH preoperative planning and modeling services with updated RI.KNEE software for the CORI Surgical System. The platform offers both image-based and image-free registration options and is designed for partial, total, and revision knee procedures. The system’s compact footprint and broad indication range align with ASC demand for scalable robotics.

The American Joint Replacement Registry surpassed four million captured hip and knee arthroplasty procedures in 2024. Greater registry coverage and real-world outcome evidence are becoming commercially important because payers and ASC partners increasingly expect proof of implant durability, complication performance, and patient-reported outcomes.

 

Conclusion

The U.S. Orthopedic Ambulatory Surgery Center Devices Market Size & Share is positioned to increase from approximately USD 5.68 billion in 2025 to USD 14.00 billion by 2035, representing a 9.44% CAGR during 2026–2035. This outlook reflects both growing orthopedic demand and a structural redistribution of surgery from hospitals to lower-cost outpatient facilities.

Joint reconstruction will remain the largest value category, supported by strong growth in total knee, total hip, partial knee, and shoulder replacement. Sports medicine and arthroscopy will continue to provide a stable base of recurring consumable revenue. Spine, extremity, and robotic-assisted technologies are expected to contribute disproportionately to incremental growth.

The strongest products will not necessarily be those with the most complex technology. ASC buyers will favor solutions that combine clinical reliability with manageable acquisition cost, rapid setup, fewer trays, compact footprints, predictable service, and disciplined implant pricing. Manufacturers must demonstrate how their products affect the complete procedural workflow rather than focusing only on technical features.

Regional opportunity will be led by the South because of population growth, physician ownership, regulatory changes, and large orthopedic procedure bases in Texas and Florida. The West will record the fastest growth, supported by migration, high ASC penetration in states such as Arizona and Nevada, and early adoption of digital surgery. The Northeast will remain a premium evidence-driven market, while the Midwest will provide stable demand and broad community-based adoption.

For medical device manufacturers, investors, ASC operators, distributors, and health systems, the central strategic issue is not simply whether outpatient orthopedics will expand. The more important questions are which procedures can migrate safely, which facilities can support them profitably, how reimbursement will absorb implant and technology costs, and which suppliers can adapt their portfolios to ASC economics.

Companies that align implant design, capital technology, field service, financing, clinical education, reimbursement support, and outcome evidence will be best positioned to lead the next decade of the U.S. orthopedic ambulatory surgery center devices industry.

 

TABLE OF CONTENT

1. U.S. Orthopedic Ambulatory Surgery Center Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Orthopedic Implant and Device Manufacturers
1.6.2. Component, Biomaterial, and Contract Manufacturing Suppliers
1.6.3. Orthopedic Single-Specialty Ambulatory Surgery Centers
1.6.4. Multispecialty Ambulatory Surgery Centers
1.6.5. Orthopedic Physician Groups and Surgeon Owners
1.6.6. Hospital–ASC Joint Ventures and Integrated Delivery Networks
1.6.7. ASC Management Companies and Corporate Operators
1.6.8. Group Purchasing Organizations and Specialty Distributors
1.6.9. Commercial Payers, Medicare, Regulators, and Accreditation Bodies

What this section provides: This section defines the market boundary, study scope, research methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. orthopedic ambulatory surgery center devices market is measured, segmented, and validated.

2. U.S. Orthopedic Ambulatory Surgery Center Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.8. Orthopedic Procedure Migration to ASCs
2.9. ASC Device Procurement and Capital Investment Outlook

What this section provides: This section gives decision-makers a concise view of market size, growth direction, procedure migration, device demand, competitive intensity, procurement behavior, and priority opportunity areas.

3. U.S. Orthopedic Ambulatory Surgery Center Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Musculoskeletal Disease and Arthritis Burden
3.1.2. Aging Population and Growth in Mobility-Restoring Procedures
3.1.3. Migration of Orthopedic Procedures from Hospitals to ASCs
3.1.4. Expansion of Same-Day Total Joint Replacement
3.1.5. Growth in Sports Medicine, Spine, and Extremity Procedures
3.1.6. Physician Ownership and Greater Surgeon Control over Clinical Workflows
3.1.7. Commercial Payer Steering Toward Lower-Cost Sites of Care
3.1.8. Expansion of Compact Robotics and Navigation Technologies
3.2. Restraints and Their Impact Analysis
3.2.1. High Implant, Capital Equipment, and Maintenance Costs
3.2.2. ASC Facility Reimbursement and Implant Cost Pressure
3.2.3. Limited Operating-Room, Storage, and Sterile-Processing Capacity
3.2.4. Patient Selection and Postoperative Safety Requirements
3.2.5. Shortage of Trained Clinical and Sterile-Processing Personnel
3.2.6. Product Recall, Infection-Control, and Device-Safety Risks
3.3. Opportunities and Their Impact Analysis
3.3.1. Outpatient Total Knee and Total Hip Arthroplasty Expansion
3.3.2. Medicare-Reimbursed Total Shoulder Arthroplasty
3.3.3. Outpatient Spine and Sacroiliac Joint Procedures
3.3.4. Compact and Handheld Orthopedic Robotic Systems
3.3.5. Sterile-Packed Implants and Reduced-Tray Instrumentation
3.3.6. Orthobiologics and Soft-Tissue Augmentation Products
3.3.7. Digital Recovery Monitoring and Patient-Reported Outcomes
3.3.8. ASC Network Consolidation and Enterprise Contracting
3.4. Challenges and Their Impact Analysis
3.4.1. Maintaining Clinical Quality During Procedure Migration
3.4.2. Aligning Premium Technology Costs with ASC Economics
3.4.3. Managing Implant Inventory Across Multiple Surgeon Preferences
3.4.4. Emergency Transfer and Postoperative Complication Management
3.4.5. Standardizing Workflows Across Independent and Networked ASCs
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Orthopedic ASC Clinical Workflow Economics Analysis
3.7. ASC Capital Procurement Behavior Analysis
3.8. Surgeon Preference and Facility Economics Alignment
3.9. Total Cost per Orthopedic Procedure Analysis

What this section provides: This section explains the clinical, commercial, reimbursement, operational, and procurement forces shaping device demand, helping clients assess growth opportunities, adoption barriers, and execution risks.

4. U.S. Orthopedic Ambulatory Surgery Center Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of ASC Buyers
4.2.3. Bargaining Power of Device and Component Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Orthopedic Implant and Device Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. ASC Implant Inventory and Consignment Model Analysis
4.6. Impact of Digitalization and Connected Orthopedic Care
4.7. Application & Innovation Landscape
4.8. FDA Regulatory Framework Analysis
4.9. CMS ASC Reimbursement and Coverage Landscape
4.10. ASC-Covered Procedure List and Inpatient-Only List Evolution
4.11. Accreditation, Patient Safety, and Infection-Control Requirements
4.12. Import/Export Restrictions & Tariff Impact
4.13. Government Initiatives and Site-of-Care Policy Changes
4.14. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.15. ASC Value Analysis and Physician Preference Decision Framework
4.16. Capital Leasing, Subscription, and Procedure-Based Payment Models
4.17. Sustainability and Medical-Waste Management in Orthopedic ASCs

What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, procedure eligibility, pricing, supply chains, accreditation, technology adoption, and ASC procurement dynamics.

5. U.S. Orthopedic Ambulatory Surgery Center Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Joint Reconstruction Implants and Instruments
5.1.2.1. Knee Reconstruction Implants
5.1.2.2. Hip Reconstruction Implants
5.1.2.3. Shoulder Reconstruction Implants
5.1.2.4. Partial Joint Replacement Systems
5.1.2.5. Revision Components and Instruments
5.1.3. Sports Medicine and Arthroscopy Devices
5.1.3.1. Suture Anchors and Soft-Tissue Fixation Devices
5.1.3.2. Ligament Reconstruction Systems
5.1.3.3. Arthroscopy Cameras and Visualization Systems
5.1.3.4. Shavers, Burrs, and Powered Resection Devices
5.1.3.5. Fluid Management and Radiofrequency Systems
5.1.3.6. Cannulas, Sutures, and Arthroscopy Consumables
5.1.4. Spine Surgery Devices
5.1.4.1. Pedicle Screw and Rod Systems
5.1.4.2. Interbody Fusion Devices
5.1.4.3. Expandable Cages and Minimally Invasive Implants
5.1.4.4. Sacroiliac Joint Fusion Devices
5.1.4.5. Endoscopic Spine Surgery Devices
5.1.4.6. Spine Access, Navigation, and Fixation Instruments
5.1.5. Trauma, Extremity, and Small-Joint Devices
5.1.5.1. Trauma Plates and Screws
5.1.5.2. Foot and Ankle Reconstruction Devices
5.1.5.3. Hand and Wrist Devices
5.1.5.4. Elbow and Upper-Extremity Devices
5.1.5.5. Bunion and Hammertoe Correction Systems
5.1.5.6. Small-Joint Replacement Devices
5.1.6. Orthobiologics, Surgical Instruments, and Consumables
5.1.6.1. Bone Graft Substitutes
5.1.6.2. Demineralized Bone Matrices
5.1.6.3. Cellular and Synthetic Bone-Graft Materials
5.1.6.4. Soft-Tissue Augmentation Products
5.1.6.5. Powered Surgical Instruments and Accessories
5.1.6.6. Procedure Packs, Drapes, Blades, and Disposable Accessories

What this section provides: This section identifies which orthopedic implant, instrumentation, biologic, capital-equipment, and consumable categories are expected to generate the highest revenue contribution and strongest growth through 2035.

6. U.S. Orthopedic Ambulatory Surgery Center Devices Market – By Procedure Type

6.1. Overview
6.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
6.1.2. Knee Replacement Procedures
6.1.2.1. Total Knee Arthroplasty
6.1.2.2. Unicompartmental Knee Arthroplasty
6.1.2.3. Patellofemoral Joint Replacement
6.1.2.4. Selected Knee Revision Procedures
6.1.3. Hip Replacement Procedures
6.1.3.1. Total Hip Arthroplasty
6.1.3.2. Direct Anterior Hip Replacement
6.1.3.3. Partial Hip Replacement
6.1.3.4. Selected Hip Revision Procedures
6.1.4. Shoulder Reconstruction and Arthroscopy Procedures
6.1.4.1. Anatomic Total Shoulder Arthroplasty
6.1.4.2. Reverse Shoulder Arthroplasty
6.1.4.3. Rotator Cuff Repair
6.1.4.4. Shoulder Stabilization and Labral Repair
6.1.4.5. Other Shoulder Arthroscopy Procedures
6.1.5. Sports Medicine and Soft-Tissue Procedures
6.1.5.1. Anterior Cruciate Ligament Reconstruction
6.1.5.2. Meniscal Repair and Cartilage Procedures
6.1.5.3. Hip Arthroscopy
6.1.5.4. Tendon and Ligament Repair
6.1.5.5. Elbow and Ankle Sports Medicine Procedures
6.1.6. Spine, Trauma, and Extremity Procedures
6.1.6.1. Lumbar Decompression
6.1.6.2. Outpatient Spinal Fusion
6.1.6.3. Sacroiliac Joint Fusion
6.1.6.4. Fracture Fixation
6.1.6.5. Foot and Ankle Reconstruction
6.1.6.6. Hand, Wrist, and Elbow Procedures

What this section provides: This section helps clients understand device demand by orthopedic procedure, identify high-volume outpatient surgeries, and prioritize procedure areas with strong reimbursement, clinical adoption, and technology requirements.

7. U.S. Orthopedic Ambulatory Surgery Center Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Orthopedic Single-Specialty ASCs
7.1.3. Multispecialty ASCs with Orthopedic Programs
7.1.4. Physician-Owned Independent ASCs
7.1.5. Hospital-Affiliated and Joint-Venture ASCs
7.1.6. Corporate-Backed and Networked ASC Operators

What this section provides: This section explains which ASC ownership structures, facility types, and customer groups are expected to drive orthopedic device purchasing, capital investment, procedure adoption, and vendor standardization.

8. U.S. Orthopedic Ambulatory Surgery Center Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Conventional Manual Orthopedic Technologies
8.1.3. Robotic-Assisted Orthopedic Surgery Systems
8.1.3.1. Robotic Knee Surgery Systems
8.1.3.2. Robotic Hip Surgery Systems
8.1.3.3. Robotic Shoulder Surgery Systems
8.1.3.4. Robotic Spine Surgery Systems
8.1.3.5. Handheld and Compact Robotic Systems
8.1.4. Computer Navigation and Patient-Specific Planning
8.1.4.1. Image-Based Navigation
8.1.4.2. Image-Free Navigation
8.1.4.3. Patient-Specific Instrumentation
8.1.4.4. 3D Preoperative Planning
8.1.4.5. Augmented and Mixed-Reality Guidance
8.1.5. Arthroscopic and Minimally Invasive Technologies
8.1.5.1. High-Definition and 4K Visualization
8.1.5.2. Endoscopic Spine Technologies
8.1.5.3. Minimally Invasive Joint Reconstruction Instruments
8.1.5.4. Fluid Management and Tissue Ablation Systems
8.1.6. AI-Enabled, Connected, and Data-Driven Technologies
8.1.6.1. AI-Assisted Surgical Planning
8.1.6.2. Intraoperative Data and Analytics Platforms
8.1.6.3. Digital Inventory and Implant Tracking
8.1.6.4. Remote Recovery Monitoring
8.1.6.5. Patient-Reported Outcome Platforms

What this section provides: This section evaluates the technology platforms shaping outpatient orthopedic surgery, including manual systems, robotics, navigation, minimally invasive equipment, digital planning, and connected recovery workflows.

9. U.S. Orthopedic Ambulatory Surgery Center Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Manufacturer and Implant Representative Sales
9.1.3. ASC Network and Enterprise-Level Contracts
9.1.4. Integrated Delivery Network and Hospital-Affiliated Agreements
9.1.5. Group Purchasing Organization Contracts
9.1.6. Distributor and Specialty Orthopedic Supplier Sales
9.1.7. Capital Leasing, Subscription, and Procedure-Based Purchasing

What this section provides: This section helps clients understand how orthopedic devices are purchased by U.S. ASCs, including surgeon-led selection, direct contracting, GPO influence, network standardization, distribution, leasing, and procedure-based acquisition models.

10. U.S. Orthopedic Ambulatory Surgery Center Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Orthopedic ASC Procedure Volume Analysis
10.1.4. Regional ASC Infrastructure and Facility Density Analysis
10.1.5. Regional Reimbursement and Site-of-Care Dynamics
10.1.6. Regional Device Procurement and Surgeon Preference Analysis
10.1.7. State Certificate-of-Need and ASC Development Environment

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Orthopedic ASC Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Orthopedic ASC Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Orthopedic ASC Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Orthopedic ASC Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, orthopedic procedure-volume hubs, ASC development hotspots, reimbursement differences, technology-adoption clusters, and state-level commercial opportunities.

11. U.S. Orthopedic Ambulatory Surgery Center Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking by Product Portfolio
11.4. Competitive Benchmarking by ASC Market Strategy
11.5. Company Profiles
11.5.1. Stryker
11.5.2. Zimmer Biomet
11.5.3. Johnson & Johnson MedTech–DePuy Synthes
11.5.4. Smith+Nephew
11.5.5. Arthrex
11.5.6. Medtronic
11.5.7. Globus Medical
11.5.8. Enovis
11.5.9. CONMED Corporation
11.5.10. Orthofix Medical
11.5.11. Alphatec Holdings
11.5.12. SI-BONE
11.5.13. Exactech
11.5.14. MicroPort Orthopedics
11.5.15. Paragon 28, a Zimmer Biomet Company
11.5.16. Treace Medical Concepts
11.5.17. Acumed
11.5.18. B. Braun–Aesculap
11.5.19. KARL STORZ
11.5.20. Olympus Corporation
11.5.21. Brainlab
11.5.22. THINK Surgical
11.5.23. GE HealthCare
11.5.24. Siemens Healthineers
11.5.25. Medline Industries

Note: Each company profile will include company overview, orthopedic ASC device portfolio, U.S. market strategy, financial positioning, product pipeline, robotic and navigation capabilities, regulatory updates, ASC partnerships, contracting approach, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, ASC commercialization strategies, innovation direction, contracting capabilities, and strategic intelligence on major orthopedic device companies.

12. U.S. Orthopedic Ambulatory Surgery Center Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Compact and Handheld Orthopedic Robotics
12.2.2. Image-Free Navigation and Patient-Specific Planning
12.2.3. AI-Assisted Orthopedic Surgical Workflows
12.2.4. Endoscopic and Minimally Invasive Spine Technologies
12.2.5. Sterile-Packed Implants and Reduced-Tray Instrumentation
12.2.6. Digital Recovery Monitoring and Remote Rehabilitation
12.2.7. Smart Implant and Outcome-Tracking Technologies
12.3. Future Orthopedic Procedure Migration to ASCs
12.4. Emerging ASC Ownership and Consolidation Trends
12.5. Emerging Business and Reimbursement Trends
12.6. Business Opportunities for Startups and Existing Players
12.7. Investment Prioritization Matrix
12.8. High-Potential Product–Procedure Opportunity Matrix

What this section provides: This section prepares clients for future technology shifts, procedure migration, reimbursement changes, market-structure developments, investment opportunities, and potential adoption scenarios through 2035.

13. U.S. Orthopedic Ambulatory Surgery Center Devices Market: Strategic Recommendations

13.1. Recommendations for Orthopedic Device Manufacturers
13.2. Recommendations for ASC Operators and Management Companies
13.3. Recommendations for Orthopedic Physician Groups and Surgeon Owners
13.4. Recommendations for Hospitals and Health Systems
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. ASC-Focused Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. Implant Pricing and Contracting Recommendations
13.11. Capital Equipment Financing and Utilization Strategy
13.12. Surgeon Training and Clinical Adoption Strategy
13.13. State-Level Market Entry Prioritization

What this section provides: This section converts market intelligence into actionable strategy for growth planning, ASC account targeting, product positioning, contracting, channel expansion, capital investment, and competitive differentiation.

14. U.S. Orthopedic Ambulatory Surgery Center Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Procedure Eligibility and Reimbursement Disclaimer
14.7. State Regulatory and Certificate-of-Need Disclaimer

What this section provides: This section clarifies the report’s limitations, legal boundaries, data-use terms, forecasting assumptions, reimbursement considerations, and state-level regulatory qualifications.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Market Definition and Scope
TABLE 3: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Research Methodology Framework
TABLE 4: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Key Assumptions
TABLE 5: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Stakeholder Analysis
TABLE 7: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Market Attractiveness Index
TABLE 10: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Orthopedic Ambulatory Surgery Center Devices Market: High-Growth Opportunity Areas
TABLE 14: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Orthopedic Procedure Migration to ASCs
TABLE 15: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Drivers; Impact Analysis
TABLE 16: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Restraints; Impact Analysis
TABLE 17: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Opportunities; Impact Analysis
TABLE 18: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Challenges; Impact Analysis
TABLE 19: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Orthopedic ASC Clinical Workflow Economics Matrix
TABLE 21: U.S. Orthopedic Ambulatory Surgery Center Devices Market: ASC Capital Procurement Behavior Matrix
TABLE 22: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Surgeon Preference and Facility Economics Matrix
TABLE 23: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Total Cost per Orthopedic Procedure Analysis
TABLE 24: U.S. Orthopedic Ambulatory Surgery Center Devices Market: PESTEL Analysis
TABLE 25: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Device Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Value Chain Analysis
TABLE 28: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Supply Chain Analysis
TABLE 29: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Implant Inventory and Consignment Model Analysis
TABLE 30: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Digitalization and Connected Orthopedic Care Impact
TABLE 31: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Application & Innovation Landscape
TABLE 32: U.S. Orthopedic Ambulatory Surgery Center Devices Market: FDA Regulatory Framework Analysis
TABLE 33: U.S. Orthopedic Ambulatory Surgery Center Devices Market: CMS ASC Reimbursement and Coverage Landscape
TABLE 34: U.S. Orthopedic Ambulatory Surgery Center Devices Market: ASC-Covered Procedure List Analysis
TABLE 35: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Accreditation and Infection-Control Requirements
TABLE 36: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 37: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Site-of-Care Policy and Government Initiatives
TABLE 38: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Geopolitical and Supply-Chain Risk Impact
TABLE 39: U.S. Orthopedic Ambulatory Surgery Center Devices Market: ASC Value Analysis Decision Framework
TABLE 40: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Capital Leasing and Procedure-Based Payment Models
TABLE 41: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Product Category Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Product Category
TABLE 43: U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 44: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 45: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Joint Reconstruction Implants and Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Sports Medicine and Arthroscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Spine Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Trauma, Extremity, and Small-Joint Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Orthobiologics, Surgical Instruments, and Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Procedure Type Snapshot, 2025
TABLE 51: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 52: U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 53: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Segment Share Analysis, by Procedure Type, 2025 & 2035 (%)
TABLE 54: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Knee Replacement Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Hip Replacement Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Shoulder Reconstruction and Arthroscopy Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Sports Medicine and Soft-Tissue Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Spine, Trauma, and Extremity Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Orthopedic Ambulatory Surgery Center Devices Market: End User Snapshot, 2025
TABLE 60: Segment Dashboard; Definition and Scope, by End User
TABLE 61: U.S. Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 62: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 63: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Orthopedic Single-Specialty ASCs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Multispecialty ASCs with Orthopedic Programs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Physician-Owned Independent ASCs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Hospital-Affiliated and Joint-Venture ASCs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Corporate-Backed and Networked ASC Operators Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Technology Type Snapshot, 2025
TABLE 69: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 70: U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 71: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 72: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Conventional Manual Orthopedic Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Robotic-Assisted Orthopedic Surgery Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Computer Navigation and Patient-Specific Planning Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Arthroscopic and Minimally Invasive Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Orthopedic Ambulatory Surgery Center Devices Market: AI-Enabled, Connected, and Data-Driven Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Procurement Channel Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 79: U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 80: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 81: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Direct Manufacturer and Implant Representative Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Orthopedic Ambulatory Surgery Center Devices Market: ASC Network and Enterprise-Level Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Integrated Delivery Network and Hospital-Affiliated Agreements Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Distributor and Specialty Orthopedic Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Capital Leasing, Subscription, and Procedure-Based Purchasing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Regional Snapshot, 2025
TABLE 88: Segment Dashboard; Definition and Scope, by Region
TABLE 89: U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 90: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 91: West Region U.S. Orthopedic Ambulatory Surgery Center Devices Market: Regional Overview and Trends
TABLE 92: West Region U.S. Orthopedic Ambulatory Surgery Center Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 93: West Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 99: California Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 100: California Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 101: California Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: California Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 103: California Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 104: Washington Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 105: Washington Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 106: Washington Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 107: Washington Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 108: Washington Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 109: Arizona Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 110: Arizona Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 111: Arizona Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 112: Arizona Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 113: Arizona Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 114: Colorado Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 115: Colorado Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 116: Colorado Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 117: Colorado Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 118: Colorado Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 119: Oregon Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 120: Oregon Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 121: Oregon Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 122: Oregon Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 123: Oregon Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 124: Utah Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 125: Utah Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 126: Utah Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 127: Utah Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 128: Utah Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 129: Nevada Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 130: Nevada Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 131: Nevada Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 132: Nevada Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 133: Nevada Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 136: New Mexico Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 138: New Mexico Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 139: Idaho Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 140: Idaho Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 141: Idaho Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 142: Idaho Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 143: Idaho Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 144: Montana Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 145: Montana Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 146: Montana Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 147: Montana Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 148: Montana Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 151: Wyoming Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 153: Wyoming Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 154: Alaska Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 155: Alaska Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 156: Alaska Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 157: Alaska Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 158: Alaska Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 161: Hawaii Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 163: Hawaii Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 164: Northeast Region U.S. Orthopedic Ambulatory Surgery Center Devices Market: Regional Overview and Trends
TABLE 165: Northeast Region U.S. Orthopedic Ambulatory Surgery Center Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 166: Northeast Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 171: Northeast Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 172: New York Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 173: New York Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 174: New York Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 175: New York Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 176: New York Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 181: Massachusetts Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 184: New Jersey Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 186: New Jersey Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 191: Pennsylvania Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 194: Connecticut Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 196: Connecticut Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 197: Maine Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 198: Maine Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 199: Maine Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 200: Maine Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 201: Maine Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 202: Vermont Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 203: Vermont Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 204: Vermont Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 205: Vermont Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 206: Vermont Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 211: New Hampshire Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 216: Rhode Island Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 217: Delaware Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 218: Delaware Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 219: Delaware Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: Delaware Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 221: Delaware Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 222: South Region U.S. Orthopedic Ambulatory Surgery Center Devices Market: Regional Overview and Trends
TABLE 223: South Region U.S. Orthopedic Ambulatory Surgery Center Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 224: South Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 229: South Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 230: Texas Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 231: Texas Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 232: Texas Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 233: Texas Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 234: Texas Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 235: Florida Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 236: Florida Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 237: Florida Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 238: Florida Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 239: Florida Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 240: Georgia Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 241: Georgia Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 242: Georgia Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 243: Georgia Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 244: Georgia Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 249: North Carolina Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 253: Tennessee Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 254: Tennessee Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 258: South Carolina Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 259: South Carolina Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 260: Alabama Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 261: Alabama Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 262: Alabama Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 263: Alabama Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 264: Alabama Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 268: Mississippi Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 269: Mississippi Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 273: Louisiana Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 274: Louisiana Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 278: Arkansas Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 279: Arkansas Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 283: Kentucky Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 284: Kentucky Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 289: Oklahoma Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 290: Virginia Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 291: Virginia Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 292: Virginia Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 293: Virginia Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 294: Virginia Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 295: Maryland Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 296: Maryland Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 297: Maryland Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 298: Maryland Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 299: Maryland Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: West Virginia Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 304: West Virginia Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 305: Midwest Region U.S. Orthopedic Ambulatory Surgery Center Devices Market: Regional Overview and Trends
TABLE 306: Midwest Region U.S. Orthopedic Ambulatory Surgery Center Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 307: Midwest Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 312: Midwest Region U.S. Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 313: Illinois Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 314: Illinois Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 315: Illinois Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 316: Illinois Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 317: Illinois Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 318: Ohio Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 319: Ohio Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 320: Ohio Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 321: Ohio Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 322: Ohio Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 323: Michigan Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 324: Michigan Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 325: Michigan Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 326: Michigan Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 327: Michigan Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 329: Minnesota Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 330: Minnesota Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 331: Minnesota Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 332: Minnesota Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 333: Indiana Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 334: Indiana Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 335: Indiana Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 336: Indiana Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 337: Indiana Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 342: Wisconsin Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 343: Missouri Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 344: Missouri Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 345: Missouri Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 346: Missouri Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 347: Missouri Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 348: Iowa Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 349: Iowa Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 350: Iowa Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 351: Iowa Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 352: Iowa Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 353: Kansas Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 354: Kansas Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 355: Kansas Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 356: Kansas Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 357: Kansas Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 359: Nebraska Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 360: Nebraska Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 361: Nebraska Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 362: Nebraska Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 364: North Dakota Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 365: North Dakota Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 366: North Dakota Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 367: North Dakota Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Orthopedic Ambulatory Surgery Center Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 369: South Dakota Orthopedic Ambulatory Surgery Center Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 370: South Dakota Orthopedic Ambulatory Surgery Center Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 371: South Dakota Orthopedic Ambulatory Surgery Center Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 372: South Dakota Orthopedic Ambulatory Surgery Center Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 373: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Competitive Landscape Snapshot, 2025
TABLE 374: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Key Company Market Share Analysis, 2025
TABLE 375: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Company Positioning Matrix
TABLE 376: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 377: U.S. Orthopedic Ambulatory Surgery Center Devices Market: ASC Strategy Benchmarking of Key Players
TABLE 378: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 379: Stryker: Company Profile
TABLE 380: Zimmer Biomet: Company Profile
TABLE 381: Johnson & Johnson MedTech–DePuy Synthes: Company Profile
TABLE 382: Smith+Nephew: Company Profile
TABLE 383: Arthrex: Company Profile
TABLE 384: Medtronic: Company Profile
TABLE 385: Globus Medical: Company Profile
TABLE 386: Enovis: Company Profile
TABLE 387: CONMED Corporation: Company Profile
TABLE 388: Orthofix Medical: Company Profile
TABLE 389: Alphatec Holdings: Company Profile
TABLE 390: SI-BONE: Company Profile
TABLE 391: Exactech: Company Profile
TABLE 392: MicroPort Orthopedics: Company Profile
TABLE 393: Paragon 28, a Zimmer Biomet Company: Company Profile
TABLE 394: Treace Medical Concepts: Company Profile
TABLE 395: Acumed: Company Profile
TABLE 396: B. Braun–Aesculap: Company Profile
TABLE 397: KARL STORZ: Company Profile
TABLE 398: Olympus Corporation: Company Profile
TABLE 399: Brainlab: Company Profile
TABLE 400: THINK Surgical: Company Profile
TABLE 401: GE HealthCare: Company Profile
TABLE 402: Siemens Healthineers: Company Profile
TABLE 403: Medline Industries: Company Profile
TABLE 404: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 405: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Disruptive Technologies Impact Matrix
TABLE 406: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Future Orthopedic Procedure Migration Matrix
TABLE 407: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Emerging ASC Ownership and Consolidation Trends
TABLE 408: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Emerging Business and Reimbursement Trends
TABLE 409: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Business Opportunities for Startups and Existing Players
TABLE 410: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Investment Prioritization Matrix
TABLE 411: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Product–Procedure Opportunity Matrix
TABLE 412: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 413: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Strategic Recommendations for ASC Operators
TABLE 414: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Strategic Recommendations for Orthopedic Physician Groups
TABLE 415: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 416: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 417: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 418: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 419: U.S. Orthopedic Ambulatory Surgery Center Devices Market: ASC-Focused Go-to-Market Strategy
TABLE 420: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 421: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Implant Pricing and Contracting Recommendations
TABLE 422: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Capital Equipment Financing Strategy
TABLE 423: U.S. Orthopedic Ambulatory Surgery Center Devices Market: State-Level Market Entry Prioritization
TABLE 424: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Scope Limitation
TABLE 425: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Data Use Limitation
TABLE 426: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Forecasting Limitation
TABLE 427: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Legal Disclaimer
TABLE 428: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Third-Party Data Disclaimer
TABLE 429: U.S. Orthopedic Ambulatory Surgery Center Devices Market: Procedure Eligibility and Reimbursement Disclaimer
TABLE 430: U.S. Orthopedic Ambulatory Surgery Center Devices Market: State Regulatory and Certificate-of-Need Disclaimer

List of Figures

FIGURE 1: U.S. Orthopedic Ambulatory Surgery Center Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Map
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Orthopedic ASC Clinical Workflow Economics Framework
FIGURE 12: ASC Capital Procurement Decision Framework
FIGURE 13: Surgeon Preference and Facility Economics Framework
FIGURE 14: U.S. Orthopedic Ambulatory Surgery Center Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 15: U.S. Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 16: U.S. Orthopedic Ambulatory Surgery Center Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 17: Orthopedic Procedure Migration to ASCs, 2021–2035
FIGURE 18: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Joint Reconstruction Implants and Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Sports Medicine and Arthroscopy Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Spine Surgery Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Trauma, Extremity, and Small-Joint Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Orthobiologics, Surgical Instruments, and Consumables Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Procedure Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Knee Replacement Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Hip Replacement Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Shoulder Reconstruction and Arthroscopy Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Sports Medicine and Soft-Tissue Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Spine, Trauma, and Extremity Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 33: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Orthopedic Single-Specialty ASCs Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Multispecialty ASCs with Orthopedic Programs Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Physician-Owned Independent ASCs Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Hospital-Affiliated and Joint-Venture ASCs Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Corporate-Backed and Networked ASC Operators Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 40: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Conventional Manual Orthopedic Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Robotic-Assisted Orthopedic Surgery Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Computer Navigation and Patient-Specific Planning Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Arthroscopic and Minimally Invasive Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: AI-Enabled, Connected, and Data-Driven Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 47: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Direct Manufacturer and Implant Representative Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: ASC Network and Enterprise-Level Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Integrated Delivery Network and Hospital-Affiliated Agreements Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Distributor and Specialty Orthopedic Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Capital Leasing, Subscription, and Procedure-Based Purchasing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. Orthopedic Ambulatory Surgery Center Devices Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: California Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Washington Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Arizona Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Colorado Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Oregon Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Utah Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Nevada Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: New Mexico Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Idaho Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Montana Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Wyoming Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Alaska Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Hawaii Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Northeast Region U.S. Orthopedic Ambulatory Surgery Center Devices Market Share and Leading Players, 2025
FIGURE 73: Northeast Region Market Share Analysis by State, 2025
FIGURE 74: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New York Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Massachusetts Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New Jersey Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Pennsylvania Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Connecticut Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Maine Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Vermont Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Hampshire Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Rhode Island Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Delaware Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: South Region U.S. Orthopedic Ambulatory Surgery Center Devices Market Share and Leading Players, 2025
FIGURE 86: South Region Market Share Analysis by State, 2025
FIGURE 87: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Texas Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Florida Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Georgia Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: North Carolina Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Tennessee Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: South Carolina Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Alabama Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Mississippi Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Louisiana Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Arkansas Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Kentucky Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Oklahoma Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Virginia Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Maryland Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: West Virginia Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Midwest Region U.S. Orthopedic Ambulatory Surgery Center Devices Market Share and Leading Players, 2025
FIGURE 104: Midwest Region Market Share Analysis by State, 2025
FIGURE 105: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Illinois Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Ohio Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Michigan Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Minnesota Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Indiana Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Wisconsin Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Missouri Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Iowa Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Kansas Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Nebraska Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: North Dakota Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: South Dakota Orthopedic Ambulatory Surgery Center Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 119: Company Positioning Matrix
FIGURE 120: Key Player Product Portfolio Benchmarking
FIGURE 121: Key Player ASC Strategy Benchmarking
FIGURE 122: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 123: Orthopedic ASC Device Innovation Roadmap
FIGURE 124: Compact and Handheld Orthopedic Robotics Adoption Roadmap
FIGURE 125: Image-Free Navigation and Patient-Specific Planning Opportunity Map
FIGURE 126: Endoscopic and Minimally Invasive Spine Technology Roadmap
FIGURE 127: Digital Recovery Monitoring Growth Roadmap
FIGURE 128: Future Market Scenario Analysis, 2026–2035
FIGURE 129: Disruptive Technologies Impact Matrix
FIGURE 130: Future Orthopedic Procedure Migration Matrix
FIGURE 131: Emerging ASC Ownership and Consolidation Trends Matrix
FIGURE 132: Emerging Business and Reimbursement Trends Matrix
FIGURE 133: Investment Prioritization Matrix
FIGURE 134: Product–Procedure Opportunity Matrix
FIGURE 135: Strategic Growth Roadmap for U.S. Orthopedic ASC Device Companies
FIGURE 136: ASC-Focused Go-to-Market Strategy Framework
FIGURE 137: Product Positioning and Portfolio Expansion Framework
FIGURE 138: Implant Pricing and Contracting Framework
FIGURE 139: Capital Equipment Financing and Utilization Framework
FIGURE 140: State-Level Market Entry Prioritization Map
FIGURE 141: Report Scope and Disclaimer Framework